Ablynx

Showing 15 posts of 19 posts found.

robert_friesen

Former Ablynx exec joins Kiadis as Chief Scientific Officer

February 5, 2019
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Ablynx, appointment, kiadis, pharma

Dutch/US firm Kiadis Pharma revealed that Dr Robert Friesen became its new Chief Science Officer (CSO) as January turned into …

ablynx_flags-web

Ablynx’s vobarilizumab trial fails and sees two patient deaths in systemic lupus erythematosus

March 26, 2018
Research and Development, Sales and Marketing AbbVie, Ablynx, Sanofi, Vobarilizumab, pharma, systemic lupus erythematosus

Ablynx has revealed that its interleukin 6 pathway via its IL-6 receptor (IL-6R) vobarilizumab failed to meet its primary endpoint …

Sanofi swoops for Ablynx in $4.8bn deal

January 29, 2018
Sales and Marketing Ablynx, Sanofi, biotech, drugs, pharma, pharmaceutical

Sanofi has moved quickly to tie up a deal with Ablynx for $4.8 billion, when it looked more likely that …

ablynx_flags-web

Novo Nordisk ups acquisition bid to €2.6 billion, Ablynx says no

January 8, 2018
Sales and Marketing Ablynx, Novo Nordisk, acquisition, pharma

It has emerged that Novo Nordisk has extended a bid of €2.6 billion to buy Belgian biotech Ablynx. The new …

ablynx_building_web

Ablynx posts strong data on key drug, looks set for approval

October 2, 2017
Research and Development, Sales and Marketing Ablynx, biotech, drugs, pharma, pharmaceutical

In a major success for the European biotech industry, Ablynx has revealed that it had met the primary and secondary …

Sanofi makes moves with strategic $2.4 billion Ablynx nanobody deal

July 20, 2017
Sales and Marketing Ablynx, Sanofi, biotech, drugs, nanobody, pharma, pharmaceutical

Sanofi is steadily recovering from missing out on Actelion to J&J by making another deal, this time with Ablynx biotech …

Ablynx secures first €1m milestone payment from Novo Nordisk

December 5, 2016
Sales and Marketing Ablynx, Novo Nordisk, nanobody

Ablynx has secured €1 million from Novo Nordisk as it hits its first discovery milestone for its multi-specific nanobody construct, …

ablynx_flags-web

Ablynx’s RA therapy matches Roche’s Actemra in Phase IIb trial

July 7, 2016
Medical Communications, Research and Development Ablynx, Actemra, Roche

Ablynx (EBR: ABLX) has presented positive data on their rheumatoid arthritis treatment candidate, ALX-0061 (vobarilizumab), in patients with rheumatoid arthritis …

Ablynx CEO Edwin Moses

Ablynx sets focus on pharma collaborations

December 14, 2015
Manufacturing and Production, Research and Development Ablynx, collaboration, nanobodies, partnership

Drug development companies should prioritise strategic pharma collaborations to keep up with the next wave of immuno-oncology treatments, the chief …

robert_k

Ablynx appoints Robert Zeldin as new chief medical officer

November 30, 2015
Manufacturing and Production, Research and Development, Sales and Marketing Ablynx, Robert Zeldin

Ablynx has appointed Dr Robert Zeldin as chief medical officer (CMO) effective from 1 December 2015.  Dr Zeldin will lead …

Ablynx flags

Ablynx and Merck begin immuno-oncology collaboration

October 15, 2015
Research and Development Ablynx, Merck, immuno-oncology, nanobody, proof of concept

Ablynx has achieved a pre-clinical proof-of-concept with a nanobody construct as part of its immuno-oncology collaboration with Merck – triggering …

johan_halen_ablynx

Ablynx looks to GSK for new chief commercial officer

November 21, 2014
Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Ablynx, johan heylan

Belgium-based biopharma firm Ablynx has appointed Johan Heylen to be its chief commercial officer and assume responsibility for all commercial …

Latest content